ROYAL BANK OF CANADA - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 164 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$8,792,000
+11.1%
203,472
+8.7%
0.01%
+40.0%
Q2 2015$7,911,000
+15.5%
187,187
+5.9%
0.01%0.0%
Q1 2015$6,852,000
+27.1%
176,690
+10.4%
0.01%
+66.7%
Q4 2014$5,390,000
+7.4%
160,113
+11.7%
0.00%0.0%
Q3 2014$5,018,000
+64.3%
143,289
+54.1%
0.00%
+50.0%
Q2 2014$3,055,000
+58.9%
92,969
+78.2%
0.00%
+100.0%
Q1 2014$1,922,000
-10.4%
52,163
-6.6%
0.00%
-50.0%
Q4 2013$2,145,000
+62.1%
55,851
+15.6%
0.00%
+100.0%
Q3 2013$1,323,000
+30.2%
48,300
-0.2%
0.00%0.0%
Q2 2013$1,016,00048,4000.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 448,361$15,096,00021.12%
Sloane Robinson LLP 107,400$3,616,0006.28%
Sensato Investors LLC 327,754$11,035,0003.26%
Grandeur Peak Global Advisors, LLC 388,810$13,091,0002.94%
GRATRY & Co LLC 205,800$7,899,0002.59%
THOMAS WHITE INTERNATIONAL LTD 464,926$15,654,0002.15%
COMGEST GLOBAL INVESTORS S.A.S. 1,819,980$61,279,0001.87%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,169,686$39,383,0001.64%
Ninety One North America, Inc. 133,372$4,491,0001.32%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 87,560$2,948,0001.27%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders